Related Experiment Videos

Synthesis of elementary single-disease recommendations to support guideline-based therapeutic decision for complex

Gersende Georg1, Brigitte Séroussi, Jacques Bouaud

  • 1STIM, DPA/DSI, AP-HP-Paris, 91 boulevard de l'Hôpital, 75634 Paris Cedex 13, France. gge@biomath.jussieu.fr

Insights

Clinical practice guidelines (CPGs) often fail complex patients. This study developed a system to automatically generate decision rules from CPGs, aiding physicians in managing multiple conditions and therapeutic decisions.

Area of Science:

  • Medical Informatics
  • Clinical Decision Support Systems
  • Artificial Intelligence in Healthcare

Background:

  • Clinical practice guidelines (CPGs) typically address single diseases, lacking support for patients with multiple comorbidities.
  • Existing computer-based systems often handle complex patient cases, but integration with CPGs can be challenging.

Purpose of the Study:

  • To develop a module for automatically generating IF-THEN-WITH decision rules from GEM-encoded CPGs.
  • To enhance decision support for physicians managing patients with multiple diseases.

Main Methods:

  • Utilized GEM-encoded instances of CPGs to develop a rule generation module.
  • Implemented a two-stage unification process for rule synthesis, eliminating redundancies and incoherences.
  • Triggered rules based on partial matching with patient clinical profiles.

Main Results:

  • Successfully generated IF-THEN-WITH decision rules from CPGs.
  • A synthesis process effectively managed rule redundancies and incoherences.
  • Physicians were presented with remaining, potentially contradictory, recommendations for final decision-making.

Conclusions:

  • The developed system provides valuable decision support for complex patients with multiple diseases.
  • Physician oversight is maintained, allowing them to manage therapeutic controversies.
  • This approach bridges the gap between CPGs and the management of multimorbidity.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...